ArticleJapanese journal of radiology2026
Novel silicon-based material decomposition images in diagnosis of pancreatic ductal adenocarcinoma: comparison with iodine-based and 50-keV virtual monoenergetic images.
Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo identify the optimal material decomposition (MD) images for diagnosis of pancreatic ductal adenocarcinoma (PDAC) and evaluate the added value of the MD image to 50-keV virtual monoenergetic images (VMIs) by comparing with iodine-based images and 50-keV VMIs.
methodsThis retrospective study included patients who underwent pancreatic protocol dual-energy CT (DECT) between February 2019 and May 2023. First, a radiologist evaluated 702 image datasets generated using 27 different materials to identify the top three MD images which provided maximum contrast difference between normal pancreas and PDAC, and subsequently, the best MD image was selected based on z value and image quality by four radiologists. Then, another four radiologists independently interpreted the conventional image dataset (iodine-based images and 50-keV VMIs) and new optimal image dataset (optimal MD images and 50-keV VMIs), and graded the presence or absence of PDAC. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were compared between the two image datasets using generalized estimating equations.
resultsOverall, 110 patients (median age, 73 years; 63 men) were included. Among them, 67 patients (61%) had pathologically proven PDAC, and the optimal MD image selected was Silicon/Struvite. The optimal image dataset had higher specificity (88% vs. 81%; P = 0.006), PPV (93% vs. 89%; P < 0.001), and accuracy (94% vs. 92%; P = 0.01) than the conventional image dataset. No difference was found in the sensitivity (P = 0.34) and NPV (P = 0.33) between the two image datasets.
conclusionSilicon/Struvite images provided high contrast difference between normal pancreas and PDAC and higher diagnostic performance for diagnosis of PDAC in combination of 50-keV VMIs compared to iodine-based images and 50-keV VMIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.